RICT 2019
Conferences > Archives > RICT 2019

Confirmed Speakers


Plenary Speakers

PL16: Straightforward Conversion of Peptides into Bioactive Lactam-Based Foldamers
Prof. Muriel AMBLARDProf. Muriel AMBLARD
(CNRS-UNIVERSTY OF MONTPELLIER I, Montpellier, France)

Read more
PL09: Chemical Physiology of Antibody Conjugates and Natural Products
Prof. Gonçalo BERNARDESProf. Gonçalo BERNARDES
(INSTITUTO DE MEDICINA MOLECULAR, PORTUGAL & UNIVERSITY OF CAMBRIDGE, Cambridge, United Kingdom)

Read more
PL13: Complex Glycans in Health and Disease
Prof. Geert-Jan BOONSProf. Geert-Jan BOONS
(UTRECHT UNIVERSITY, Utrecht, The Netherlands)

Read more
PL18: Modulating Different Components of the Ubiquitin System with Small Molecules and Cyclic Peptides
Prof. Ashraf BRIKProf. Ashraf BRIK
(TECHNION-ISRAEL INSTITUTE OF TECHNOLOGY, Haifa, Israel)

Read more
PL07: The Influence of Free Ligand Conformations on Mcl-1 PPI Inhibition
Dr Rodrigo CARBAJODr Rodrigo CARBAJO
(ASTRAZENECA, Cambridge, United Kingdom)

Read more
PL12: Carbohydrate-Lectin Interactions - What Makes Them Unique?
Prof. Dr Beat ERNSTProf. Dr Beat ERNST
(UNIVERSITY OF BASEL, Basel, Switzerland)

Read more
PL03: Quo Vadis Small Molecule Cancer Therapeutics?
Dr Ingo HARTUNGDr Ingo HARTUNG
(BAYER HEALTHCARE, Darmstadt, Germany)

Read more
PL15: Identification of S 64315, a Potent and Selective Mcl-1 Inhibitor through Fragment-based Drug Discovery
Dr Andras KOTSCHYDr Andras KOTSCHY
(SERVIER RESEARCH INSTITUTE OF MEDICINAL CHEMISTRY, Budapest, Hungary)

Read more
PL11: Increasing Brain Exposure of Therapeutic Antibodies
Dr Dominique LESUISSEDr Dominique LESUISSE
(SCT & SANOFI, Chilly-Mazarin, France)

Read more
PL04: Massively Multi-target Profile-QSAR: IC50 Predictions Comparable to 4-Concentration Experiments for most Novartis Assays
Dr Eric MARTINDr Eric MARTIN
(NOVARTIS, Emeryville, United States)

Read more
PL01: What Makes a Great Medicinal Chemist: Some Fresh Thoughts
Dr Mark MURCKODr Mark MURCKO
(RELAY THERAPEUTICS, Boston, MA, United States)

Read more
PL19: Cysteine Arylation to Engineer, Deliver, and Discover Proteins
Prof. Bradley Lether PENTELUTEProf. Bradley Lether PENTELUTE
(MASSACHUSETTS INSTITUTE OF TECHNOLOGY, Cambridge, MA, United States)

Read more
PL06: Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 (SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA)
Dr Hasane RATNIDr Hasane RATNI
(F. HOFFMANN-LA ROCHE LTD, Basel , Switzerland)

Read more
PL17: Chemical Biology of mRNA Modifications
Prof. Andrea RENTMEISTERProf. Andrea RENTMEISTER
(UNIVERSITY OF MÜNSTER, Münster, Germany)

Read more
PL10: Click-Cleavable Antibody-Drug Conjugates
Dr Marc ROBILLARDDr Marc ROBILLARD
(TAGWORKS PHARMACEUTICALS, Eindhoven, The Netherlands)

Read more
PL02: Reprogramming the Reactivity of Iron in Cancer
Dr Raphaël RODRIGUEZDr Raphaël RODRIGUEZ
(INSTITUT CURIE, Paris, France)

Read more
PL05: Automated Syntheses Planning and its Implications for Drug Design
Dr Marwin SEGLERDr Marwin SEGLER
(BENEVOLENTAI, Cambridge, United Kingdom)

Read more
PL20: Pierre Fabre Award Lecture - Click Chemistry with Mesoionics: New Tools for Chemical Biology
Dr Frédéric TARANDr Frédéric TARAN
(CEA/SACLAY, Gif-sur-Yvette, France)

Read more
PL08: Paul Ehrlich Award Lecture - Chemotype - Phenotype - Target
Prof. Herbert WALDMANNProf. Herbert WALDMANN
(MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY, Dortmund, Germany)

Read more
PL14: Unlocking Drug Discovery Power through Collaborative Efforts between Academia and CRO : Bringing Novel Tankyrase Inhibitors towards the Clinic
Dr Anita WEGERTDr Anita WEGERT
(MERCACHEM-SYNCOM, Nijmegen, The Netherlands)

Read more

Keynote Speakers

KL01: Therapeutic Potential of Macrocyclic ALK2 Inhibitors
Dr Pascal BENDERITTERDr Pascal BENDERITTER
(ONCODESIGN, Dijon, France)

Read more
KL03: Nanofitin Modules Platform: Go Multispecific, Go Multiparatopic !
Dr Anne CHEVRELDr Anne CHEVREL
(AFFILOGIC, Nantes, France)

Read more
KL02: Tackling a Unique S1 Protease by SBDD - Highly Potent & Selective Factor D Inhibitors - Age-Related Macular Generation (AMD)
Dr Edwige LORTHIOISDr Edwige LORTHIOIS
(NOVARTIS, Basel, Switzerland)

Read more

Organised by

Supported by

EFMC Sponsored Event

Sponsors

Copyright 2024 LD Organisation srl  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 (0)10 45 47 77  |   |  VAT: BE 0464819842
Developed and powered by Antalys